West Pharmaceutical Services, Inc. Stock Sao Paulo
Stocks
W2ST34
BRW2STBDR007
Medical Equipment, Supplies & Distribution
|
Delayed
Sao Paulo
21:53:32 08/09/2026 +04
|
5-day change | 1st Jan Change | ||
| 49.25 BRL | -2.36% |
|
-.--% | +20.83% |
| 04:25pm | Barclays Raises West Pharmaceutical Services Price Target to $440 From $400, Maintains Overweight Rating | MT |
| 09-23 | US companies face rise in cyber attacks | RE |
| Market Cap | 26.51B 132B 23.54B 22.03B 19.96B 37.7B 2,556B 37.98B 265B 103B 1,304B 99.53B 97.39B 4,192B | P/E 2026 * |
43.9x | P/E 2027 * | 38.2x |
|---|---|---|---|---|---|
| Enterprise Value | 26.01B 130B 23.09B 21.61B 19.59B 36.99B 2,507B 37.26B 260B 101B 1,279B 97.64B 95.54B 4,112B | EV / Sales 2026 * |
7.71x | EV / Sales 2027 * | 7.12x |
| Free-Float |
92.88% | Yield 2026 * |
0.24% | Yield 2027 * | 0.26% |
Last Transcript: West Pharmaceutical Services, Inc.
| 1 day | -2.36% | ||
| 1 month | -2.36% | ||
| 3 months | +10.62% | ||
| 6 months | +37.72% | ||
| Current year | +20.83% |
| 1 month | 49.25 |  | 49.25 |
| Current year | 34.5 | | 53.25 |
| 1 year | 34.5 | | 53.25 |
| 3 years | 32.64 | | 60 |
| 5 years | 30.7 | | 75.51 |
| 10 years | 30.7 | | 75.51 |
| Manager | Title | Age | Since |
|---|---|---|---|
Michel Lagarde
CEO | Chief Executive Officer | 52 | 31/08/2026 |
Robert McMahon
DFI | Director of Finance/CFO | 57 | 04/08/2025 |
Devesh Mathur
CTO | Chief Tech/Sci/R&D Officer | - | 01/08/2025 |
| Director | Title | Age | Since |
|---|---|---|---|
Mark Buthman
BRD | Director/Board Member | 65 | 01/02/2011 |
Douglas Michels
BRD | Director/Board Member | 69 | 07/03/2011 |
William Feehery
BRD | Director/Board Member | 56 | 12/02/2012 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -2.36% | -.--% | - | - | 26.51B | |
| -1.93% | -2.77% | -26.61% | +1.31% | 173B | |
| +0.03% | -0.41% | -11.88% | +13.95% | 113B | |
| -1.20% | -0.26% | -24.09% | +4.59% | 109B | |
| +1.52% | +1.45% | -46.87% | -10.58% | 74.44B | |
| +0.46% | +2.45% | +3.22% | +71.40% | 60.1B | |
| +3.27% | +7.25% | +18.14% | +67.16% | 51.87B | |
| -0.22% | -0.84% | -6.01% | -31.24% | 49.21B | |
| -2.27% | -3.30% | -17.83% | +15.67% | 41.52B | |
| -4.05% | -3.60% | +25.87% | +0.37% | 32.79B | |
| Average | -0.68% | +0.62% | -9.56% | +14.74% | 78.34B | |
| Weighted average by Cap. | -0.63% | +0.42% | -15.78% | +11.93% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 3.38B 16.81B 3B 2.8B 2.54B 4.8B 325B 4.83B 33.67B 13.1B 166B 12.67B 12.4B 534B | 3.59B 17.86B 3.18B 2.98B 2.7B 5.1B 346B 5.14B 35.79B 13.92B 176B 13.46B 13.18B 567B |
| Net income | 621M 3.09B 552M 516M 468M 884M 59.91B 890M 6.2B 2.41B 30.56B 2.33B 2.28B 98.25B | 710M 3.54B 630M 590M 535M 1.01B 68.46B 1.02B 7.09B 2.76B 34.92B 2.67B 2.61B 112B |
| Net Debt | -503M -2.51B -447M -418M -379M -716M -48.51B -721M -5.02B -1.95B -24.75B -1.89B -1.85B -79.56B | -973M -4.85B -864M -809M -733M -1.38B -93.84B -1.39B -9.71B -3.78B -47.87B -3.65B -3.58B -154B |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- WST Stock
- W2ST34 Stock
Select your edition
All financial news and data tailored to specific country editions
